Abstract
We studied the effect of acute (1 day) and subacute (16 days) administration of the new antidepressant, nefazodone (400 mg daily), and the selective serotonin re-uptake inhibitor (SSRI), paroxetine (30 mg daily), on the sleep polysomnogram of 37 healthy volunteers using a random allocation, double-blind, placebo-controlled design. Compared to placebo, paroxetine lowered rapid eye movement (REM) sleep and increased REM latency. In addition, paroxetine increased awakenings and reduced Actual Sleep Time and Sleep Efficiency. In contrast, nefazodone did not alter REM sleep and had little effect on measures of sleep continuity. We conclude that in contrast to typical SSRIs, nefazodone administration has little effect on sleep architecture in healthy volunteers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg HP (1994) The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology 10:123–127
Friston KJ, Sharpley AL, Solomon RA, Cowen PJ (1989) Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors? Psychopharmacology 98:139–140
Gillin JC, Wyatt RJ, Fram D, Snyder F (1978) The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology 59:267–272
Kahn RS, Wetzler S (1991)m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30:1139–1166
Katsuda Y, Walsh AES, Ware CJ, Cowen PJ, Sharpley AL (1993) meta-chlorophenylpiperazine decreases slow-wave sleep in humans. Biol Psychiatry 33:49–51
Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH (1981) Sleep and treatment prediction in endogenous depression. Am J Psychiatry 138:429–433
Kupfer DJ, Perel JM, Pollock BG, Nathan RS, Grochocinski BJ, Wilson MJ, McEacharn AB (1991) Fluvoxamine versus desipramine comparative polysomnographic effects. Biol Psychiatry 29:23–40
Lawlor BA, Newhouse PA, Balkin TJ, Molchan SE, Mellow AM, Murphy DL, Sunderland T (1991) A preliminary study of the effects of night-time administration of the serotonin agonist, m-CPP, on sleep architecture and behaviour in healthy volunteers. Biol Psychiatry 29:281–286
Montgomery I, Oswald I, Morgan K, Adam K (1983) Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol 16:139–144
Monti JM (1989) Effects of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients. Br J Psychiatry 155:61–65
Nicholson AN, Pascoe PA (1986) 5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man. Neuropharmacology 25:1079–1083
Nicholson AN, Pascoe PA (1991) Monoaminergic transmission and sleep in man. In: Idzikowski C, Cowen PJ (eds) Serotonin, sleep and mental disorder. Wrightson Biomedical Publishing, Winchester, pp 215–226
Nofzinger EA, Reynolds CF III, Thas ME, Frank E, Jennings JR, Fasiczka AL, Sullivan LR, Kupfer BJ (1995) REM sleep enhancement by bupropion in depressed men. Am J Psychiatry 152:274–276
Oswald I, Adam K (1986) Effects of paroxetine on human sleep. Br J Clin Pharmacol 22:97–99
Oswald I, Adam K, Allen S, Burack R, Spence M, Thacore V (1974) Alpha adrenergic blocker, thymoxamine, and mesoridazine both increase human REM sleep duration. Sleep Res 3:62
Rechtschaffen A, Kales A (1968) A manual of standardised terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles Brain Information Service, Brain Research Institute, Univesity of California
Reynolds CF III, Kupfer DJ (1987) Sleep research in affective illness: state of the art circa 1987. Sleep 10:199–215
Rickels K, Schweizer E, Clary C, Fox I, Weise C (1994) Nefazodone and imipramine in major depression: a placebo controlled trial. Br J Psychiatry 164:802–805
Sharpley AL, Cowen PJ (1995) Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 37:85–98
Sharpley AL, Walsh AES, Cowen PJ (1992) Nefazodone — a novel antidepressant — may increase REM sleep. Biol Psychiatry 31:1070–1073
Sharpley AL, Elliott JM, Attenburrow MJ, Cowen PJ (1994) Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology 33 [3/4]:467–471
Solomon RA, Sharpley AL, Cowen PJ (1989) Increased slow wave sleep with 5-HT2 receptor antagonists: detection by ambulatory EEG monitoring and automatic sleep stage analysis. J Psychopharmacol 3:125–129
Ware JC, Rose V, McBrayer R (1991) The effects of nefazodone, trazodone, buspirone and placebo on sleep and sleep related penile erections (NPT) in normal subjects. Sleep Res 20:91
Yocca FD, Hyslop DK, Taylor DP (1985) Nefazodone: a potential broad spectrum antidepressant. Transact Am Soc Neurochem 16:115
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharpley, A.L., Williamson, D.J., Attenburrow, M.E.J. et al. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology 126, 50–54 (1996). https://doi.org/10.1007/BF02246410
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246410